The Food and Drug Administration’s recent approval of new Alzheimer’s drugs sparked a flicker of hope for the millions affected by this devastating disease. But this progress casts a puzzling shadow.
The drugs come at a high cost for relatively limited benefits, offering only a brief respite in the pace of cognitive decline. This reality raises a question: Are we fixated on such marginally effective treatments at the expense of more promising preventive measures?
Let's start with the truth!
Support the Broken Science Initiative.
Subscribe today →
recent posts
Jaynes foresaw reasoning machines aiding human inquiry, but modern AI's misuse, such as in academic fraud, underscores the necessity of scientific rigor.
As reported by the BBC, Bartlett’s podcast “is amplifying harmful health misinformation on his number-one ranked podcast.”
